Stock Update (NYSE:MRK): NewLink Genetics Corporation Announces Clinical Development Milestone Achieved With Merck for Ebola Vaccine Candidate

[GlobeNewswire] – AMES, Iowa — NewLink Genetics Corporation today announced that it had received notification from Merck that the milestone event specified in the license and collaboration agreement between the two companies … . . . → Read More: Stock Update (NYSE:MRK): NewLink Genetics Corporation Announces Clinical Development Milestone Achieved With Merck for Ebola Vaccine Candidate Similar Articles: Stock Update: Merck & Co Inc (NYSE:MRK) – Merck Completes Tender Offer to Acquire Cubist Market Update: Merck & Co Inc (NYSE:MRK) – Merck says animal food additive Zilmax seen safe in review Stock Update (NYSE:MRK): Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness